J
John D. Dickinson
Researcher at Washington University in St. Louis
Publications - 5
Citations - 177
John D. Dickinson is an academic researcher from Washington University in St. Louis. The author has contributed to research in topics: Hematopoietic stem cell transplantation & Interleukin 33. The author has an hindex of 3, co-authored 5 publications receiving 135 citations.
Papers
More filters
Journal ArticleDOI
IL13 activates autophagy to regulate secretion in airway epithelial cells
John D. Dickinson,Yael G. Alevy,Nicole P. Malvin,Khushbu Patel,Sean P. Gunsten,Michael J. Holtzman,Thaddeus S. Stappenbeck,Steven L. Brody +7 more
TL;DR: It is indicated that autophagy is essential for airway mucus secretion in a type 2, IL13-dependent immune disease process and thereby provide a novel therapeutic strategy for attenuating airway obstruction in hypersecretory inflammatory diseases such as asthma, chronic obstructive pulmonary disease, and cystic fibrosis lung disease.
Journal ArticleDOI
Early and Adequate Antibiotic Therapy in the Treatment of Severe Sepsis and Septic Shock
TL;DR: Emerging laboratory data suggest that early in the course of septic shock, the pharmacokinetics of common broad spectrum antibiotics may be significantly altered due to increased volumes of distribution having dosing implications for antibiotics in sepsis.
Book ChapterDOI
Applications of Mouse Airway Epithelial Cell Culture for Asthma Research
TL;DR: This chapter discusses the application of mouse tracheal epithelial cell cultures for the study of asthma biology with a major advantage of this system is the ability to use airway epithelial cells from mice with defined genetic backgrounds.
Journal ArticleDOI
Outcomes of Hematopoietic Stem Cell Transplantation for Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL).
John D. Dickinson,Fausto R. Loberiza,Victoria Whalen,Philip J. Bierman,Julie M. Vose,Marcel P. Devetten,Lori J. Maness,James O. Armitage,Greg Bociek +8 more
TL;DR: CLL/SLL patients undergoing allogeneic SCT had a higher incidence of early treatment related mortality, mainly from regimen related toxicity and infection and a subgroup analysis suggests pts with CLL appear to have an inferior PFS compared with pts with SLL.
Journal ArticleDOI
Soluble BAFF Is Elevated Following Allogeneic SCT but Is Not an Early Predictor for the Development of cGVHD.
John D. Dickinson,Iskra Pusic,Christoph Rader,Seth M. Steinberg,Frances T. Hakim,Sivasubramanian Baskar,Steven Z. Pavletic +6 more
TL;DR: Plasma BAFF level was significantly higher in the group with cGVHD compared to normal plasma donors and post autologous stem cell transplant breast cancer patients, and the role of BAFF expression in the context of immune reconstitution, and allogeneic GVL/GVHD is not yet understood.